Skip to main content
Clinical Trials/NCT05005364
NCT05005364
Unknown
N/A

Prospective Evaluation of the Clinical Profile and Treatment Outcomes of Proximal Humerus Fractures.

Tan Tock Seng Hospital1 site in 1 country400 target enrollmentAugust 21, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Proximal Humerus Fractures
Sponsor
Tan Tock Seng Hospital
Enrollment
400
Locations
1
Primary Endpoint
Oxford Shoulder Score - change over 6 weeks, 3, 6, 12 months
Last Updated
4 years ago

Overview

Brief Summary

With an ageing population, fragility fractures secondary to osteoporosis are on a increasing trend. Proximal humerus fractures are common fractures which account for a significant proportion of these fragility fractures. They significantly affect patients function and independence particularly in the elderly.

Currently, treatment options range from conservative treatment with an arm sling to fixation either with plates or intramedullary devices to arthroplasty ranging from a hemiarthroplasty to the latest reverse shoulder arthroplasty. While is there has been a global trend towards surgical treatment for such fractures, there is significant controversy regarding the best treatment with many studies reporting disappointing functional outcomes including residual shoulder pain, limitation in shoulder motion and decreased quality of life regardless of treatment option selected.

In this day and age where healthcare cost is a big concern both at the individual patient level but at a government level as well, evaluating the cost effectiveness of treatment becomes essential as well. Currently in Singapore, there have been a significant trend of an increased use of surgical treatment of proximal humerus fractures however we have very little data in our local context not only to evaluate the clinical effectiveness but also the cost effectiveness of surgical treatment in comparison to conservative treatment.

The primary aim of the study is

  1. To understand the epidemiology and prognostic factors for proximal humerus fractures

    • Incidence
    • Health service utilization
    • clinical and functional outcomes
  2. To estimate the relative cost-effectiveness of surgical vs non-surgical treatment pathways for managing patients with proximal humerus fractures.

We hypothesize that surgical fixation of the proximal humerus is both clinically and cost effective

Registry
clinicaltrials.gov
Start Date
August 21, 2017
End Date
December 31, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tan Tock Seng Hospital
Responsible Party
Principal Investigator
Principal Investigator

Bryan Tan

Associate Consultant

Tan Tock Seng Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 21 years old and above
  • Radiologically confirmed proximal humerus fracture
  • Within 3 weeks of their injury

Exclusion Criteria

  • Open fracture
  • Mentally incompetent patients
  • Co-morbidities precluding anaesthesia
  • Severe soft tissue compromise
  • Neurovascular compromise
  • Pathological fracture other than osteoporosis
  • Surgery delayed \> 3 weeks

Outcomes

Primary Outcomes

Oxford Shoulder Score - change over 6 weeks, 3, 6, 12 months

Time Frame: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months

A 12-item patient-report questionnaire developed to evaluate the outcome of shoulder surgery, excluding surgery for instability. The OSS contains two subscales, pain and activities of daily living. Each responses is of a 0-4 scoring format with a higher score representing better function. Hence, the highest possible total score is 48 and a higher score represents a better outcome.

QuickDASH scoring - change over 6 weeks, 3, 6, 12 months

Time Frame: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months

This score is a subset of 11 items from the 30-item DASH and is a self-reported questionnaire in which the response options are presented as 5-point Likert scales. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability).

Constant Shoulder Score - change over 6 weeks, 3, 6, 12 months

Time Frame: Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months

To evaluate the clinical outcomes over time by comparing the change in constant shoulder score over a period of 1 year. The Constant Shoulder Score is used to assess the level of pain and the patient's ability to carry out normal daily activities. Constant score of the unaffected shoulder was also assessed at baseline to compare the function between the two shoulders.

Secondary Outcomes

  • EQ5D-5L - change over 6 weeks, 3, 6, 12 months(Assessed at baseline, 6 weeks, 3 months, 6 months, 12 months)
  • Costing questionnaire(Assessed at 6 weeks, 3 months, 4.5 months, 6 months)

Study Sites (1)

Loading locations...

Similar Trials